Please assess the completion status of the following clinical trial:

Trial Title: A Randomized Controlled Trial of Treatment of Bacterial Vaginosis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Pregnant women 18 to ≤50 years with the ability to give informed consent.~* Patients expected to have a vaginal delivery with no obstetric contraindication for vaginal delivery at time of screening.~* Diagnosed with bacterial BV per Amsel criteria at time of screening in clinic.~* Gestational age ≥ 35 weeks~Exclusion Criteria:~* Plan for elective cesarean delivery~* Allergy or contraindications to metronidazole~* Receipt of metronidazole or clindamycin on admission for delivery for other indications.~* Hemodialysis~* Severe liver dysfunction~* Patient reports BV to nurse or clinician provider at current clinic visit or has been treated for BV within the past 3 months.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: f

Study Arms:
- Metronidazole 500 mg (Type: ACTIVE_COMPARATOR): Participants in this arm will receive metronidazole 500 mg twice daily, orally for 7 days
- Placebo (Type: PLACEBO_COMPARATOR): Participants in this arm will receive placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).